Cargando…
Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020
Mitochondrial diseases (MDs) are a group of genetic disorders that may manifest with vast clinical heterogeneity in childhood or adulthood. These diseases are characterized by dysfunctional mitochondria and oxidative phosphorylation deficiency. Patients are usually treated with supportive and sympto...
Autores principales: | Gruosso, Francesco, Montano, Vincenzo, Simoncini, Costanza, Siciliano, Gabriele, Mancuso, Michelangelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794679/ https://www.ncbi.nlm.nih.gov/pubmed/33383961 http://dx.doi.org/10.3390/jcm10010094 |
Ejemplares similares
-
Mitochondrial ANT-1 related adPEO leading
to cognitive impairment: is there a link?
por: Simoncini, Costanza, et al.
Publicado: (2017) -
NEWS and VIEWS: mitochondrial encephalomyopathies
por: Ienco, Elena Caldarazzo, et al.
Publicado: (2016) -
May “Mitochondrial Eve” and Mitochondrial Haplogroups Play a Role in Neurodegeneration and Alzheimer's Disease?
por: Ienco, Elena Caldarazzo, et al.
Publicado: (2011) -
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies
por: Siciliano, Gabriele, et al.
Publicado: (2012) -
Mitochondrial Epilepsy, a Challenge for Neurologists
por: Lopriore, Piervito, et al.
Publicado: (2022)